At a roundtable in Cleveland, kidney experts said IgA nephropathy and FSGS often go unrecognized, calling for EHR flags and better referral channels.
|Articles|April 11, 2012
CMS Posts Stage 2 Clinical Quality Measures
Advertisement
Health information technology users, developers, and others wanting to review or comment on the clinical quality measures in the Stage 2 meaningful-use criteria have them now laid out in a handy, downloadable spreadsheet format.
Read the full story:
Source: ModernHealthcare.com
The CMS posted the measures and descriptions about them—one sheet for hospitals and another sheet for office-based physicians and other eligible professionals—on its website.
Advertisement
Related to this article
AI quantitative CT (UCLA QILD, Brainomix e-Lung) predicts FVC decline and drug response in PPF, strengthening biomarkers beyond spirometry in INBUILD.
Medicaid expansion was associated with lower colorectal cancer mortality, with the largest reductions in Hispanic patients and stage IV disease.
These phase 3 EXCALIBER-RRMM findings build on earlier MRD-negative complete response results supporting FDA approval of the iberdomide-based regimen.
Admilparant 60 mg met the ALOFT-IPF primary end point, significantly improving FVC change vs placebo at 52 weeks in idiopathic pulmonary fibrosis.
Medicare drug price negotiations lowered out-of-pocket costs for some beneficiaries, but those reaching the annual Part D cap saw no direct savings.
The conference session featured updates on several clinical trials, including the BRUNELLO trial, for treatment of diabetic macular edema (DME).
Panelists engaged in a debate regarding using complement inhibitors in geographic atrophy, gauging public sentiment with a deciding vote.
Advertisement
Advertisement
Trending on AJMC
1
Coroner Reports Pennsylvania's Sixth Measles-Associated Death
2
CMS Rule Ends Medicaid, CHIP Funding for Pediatric Gender Care
3
Oral JAK Inhibitors Boost Hair Regrowth Odds in Alopecia Areata
4
Panel Calls for Earlier Detection, Clearer Pathways in Rare Glomerular Disease
5